Skip to content
TrialMatch
Sign up
Recruiting

Study on the Diagnosis of Ground-glass Lung Cancer by Microwave Ablation Combined With Puncture Biopsy

Create a profile to match View the full record on ClinicalTrials.gov

About this study

This study is a multicenter study. It plans to screen 200 patients with pulmonary nodule lesions with ground glass as the main body, take CT thin-layer scanning 3D reconstruction, apply AI and fragment omics technology to evaluate the risk of malignant transformation of pulmonary nodules, and use microwave ablation to treat pulmonary nodules and combine intraoperative rapid pathology technology to determine the nature of puncture tissue and the degree of ablation, and then explore the optimal ablation time and ablation power.

Condition
Lung Cancer
Tested
Microwave ablation combined with biopsy
Sponsor
Beidahuang Industry Group General Hospital

Who can join

Age
18 to 75 years
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 8

  • Minimum age: 18 years
  • Maximum age: 75 years
  • Study condition: Lung Cancer
  • Age ≤ 75 years;
  • GGN patients with the maximum axial diameter of the lesion in the lung window ≤ 3 cm;
  • Refusing radical surgery or being unable to tolerate surgical treatment;
  • Normal coagulation function, platelet count ≥ 60 × 109 /L;
  • ECOG score ≤ 2 points;

Exclusion 8

  • Patients with the maximum axial diameter of the lesion in the lung window greater than 3 cm
  • Platelets \<50×109 /L
  • Patients with severe bleeding tendency and coagulation dysfunction that cannot be corrected in the short term
  • Severe chronic obstructive pulmonary disease, emphysema, pulmonary fibrosis and pulmonary hypertension
  • Patients whose anticoagulant therapy or antiplatelet drugs have been discontinued for less than 5 days before ablation
  • Patients with severe heart, liver, kidney and brain dysfunction
  • Patients with severe anemia, dehydration and cachexia that cannot be corrected or improved in the short term
  • Patients with an estimated survival period of less than 6 months

Where

1 site, 1 recruiting

Beidahuang Industry Group General Hospital

Harbin, Heilongjiang, China

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.